Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01240330 · ClinicalTrials.gov registry record · NA

Vasculaire Compression System Increases Flow Velocity in the Femoral Vein

A NA study of Venous Thrombosis, sponsored by Venous Health Systems.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01240330 is a NA study of Venous Thrombosis that has completed, run by Venous Health Systems. The registered enrollment target is 33 participants, below the 1,121-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01240330, a NA study of Venous Thrombosis, has completed, sponsored by Venous Health Systems.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The objective of this clinical study was to demonstrate the performance of the Vasculaire Compression System to increase femoral venous peak velocity (PFV) in healthy subjects. This study was a single-arm, open label, prospective, single-center clinical study.

Conditions Studied

Interventions

  • DEVICE Pneumatic Compression therapy

Study Locations (1)

California

  • Venous Health System, Inc. - Portola Valley

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2010-08
Est. Completion 2010-09
Phase NA

Sponsor

Venous Health Systems

1 total trials

What the Registry Record Tells You About NCT01240330

The ClinicalTrials.gov registry entry for NCT01240330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,121-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (97% lower). The listed sponsor is Venous Health Systems, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Venous Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Pneumatic Compression therapy is the first listed.

NCT01240330 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01240330 about?

NCT01240330 is a clinical study titled "Vasculaire Compression System Increases Flow Velocity in the Femoral Vein". The objective of this clinical study was to demonstrate the performance of the Vasculaire Compression System to increase femoral venous peak velocity (PFV) in healthy subjects. This study was a single-arm, open label, prospective, single-center clinical study.

What is the current status of trial NCT01240330?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2010-08. Estimated completion is 2010-09.

What conditions does trial NCT01240330 study?

This clinical trial studies the following conditions: Venous Thrombosis.

What interventions are being tested in trial NCT01240330?

The interventions under investigation include: Pneumatic Compression therapy (DEVICE).

Who is sponsoring clinical trial NCT01240330?

This trial is sponsored by Venous Health Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01240330 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Thrombosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.